Drug
Who makes durvalumab?
2 companies list durvalumab as a human prescription drug, including under the names IMFINZI. Forms: injection, solution. Routes: intravenous.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing durvalumab
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| AstraZeneca PLCUnited States | injection, solution | BLABLA761069 | 2 | 15 |
| Catalent Indiana, LLCUnited States | injection, solution | DRUG FOR FURTHER PROCESSING | 1 | 1 |
Bulk ingredient listings
- AstraZeneca PLCUnited States · 1 NDC
- Boehringer Ingelheim Biopharmaceuticals China LtdGermany · 1 NDC
- Samsung Biologics Co., Ltd.United States · 1 NDC
Enquiry
Common questions
- Who makes durvalumab?
- 2 companies list durvalumab as a human prescription drug in the openFDA NDC Directory, led by AstraZeneca PLC, Catalent Indiana, LLC. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Who supplies durvalumab active ingredient?
- 3 companies list durvalumab as a bulk ingredient, including AstraZeneca PLC, Boehringer Ingelheim Biopharmaceuticals China Ltd, Samsung Biologics Co., Ltd..